HelixNano Competitors and Similar CompaniesClear all
Eutropics's competitors and similar companies include ONK Therapeutics, Arranta Bio MA and Monte Rosa Therapeutics.
 Eutropics Eutropics Pharmaceuticals is a company that develops predictive diagnostic tests for guiding patient cancer treatments. |  ONK Therapeutics ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs. |  Arranta Bio MA Arranta Bio MA is a contract development and manufacturing organization that focuses on serving companies that develop therapies targeting the human microbiome. |  Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. | |
Founding Date | Founding Date 2005 | Founding Date 2015 | Founding Date 2019 | Founding Date 2018 |
Type | Type Private | Type Private | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Barna, IE HQ | Locations Watertown, US HQ Gainesville, US | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US |
Employees | Employees 5 | Employees 176% decrease | Employees 753% increase | Employees 75 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 14.6m | Total funding raised $ 82m | Total funding raised $ 223.5m |
For sources of this data, please see the company profile
View Company Profiles
ONK Therapeutics
HQ
Barna, IE
Employees
17↓ 6% decrease
ONK Therapeutics is a company that develops natural killer cell-based therapies intended to target blood cancer with unmet needs.
View companyArranta Bio MA
HQ
Watertown, US
Arranta Bio MA is a contract development and manufacturing organization that focuses on serving companies that develop therapies targeting the human microbiome.
View companyMonte Rosa Therapeutics
HQ
Boston, US
Employees
75
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company